Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Global Blood Therapeutics
Biotech
ASH: Pfizer swims in crowded sickle cell, hemophilia waters
Novo Nordisk and Pfizer are not going head-to-head in hemophilia. But they are, at least, racing side-by-side.
Annalee Armstrong
Dec 9, 2023 7:00pm
Pfizer's $5.4B GBT buy adds potential sickle cell disease 'cure'
Aug 8, 2022 10:19am
Forma builds case for FT-4202 in competitive sickle cell space
Mar 30, 2021 8:40am
GBT adds 2 Sanofi sickle cell meds in deal worth up to $353M
Mar 16, 2021 9:55am
JPM: Imara CEO on fighting sickle cell disease during COVID-19
Jan 13, 2021 10:25am
GBT sickle cell trial hits endpoint ahead of NDA filing
Jun 14, 2019 8:53am
